Nausea and vomiting in HIV: A symptom review

International Journal of STD and AIDS

Volumn 19, Issue 11, 2008, Pages 723-728

  Chubineh, Saman ^a   McGowan, J ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

Highly active antiretroviral therapy; Nausea; Vomiting

Indexed keywords

ABACAVIR; ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPRENAVIR; AMPRENAVIR PHOSPHATE; ATAZANAVIR; ATOVAQUONE; AZITHROMYCIN; BENZACOT; CIDOFOVIR; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DAPSONE; DELAVIRDINE; DEXAMETHASONE; DIDANOSINE; DIIODOHYDROXYQUIN; DIPHENHYDRAMINE; DOLASETRON MESILATE; DRONABINOL; DROPERIDOL; EFAVIRENZ; FAMCICLOVIR; FLUCONAZOLE; FLUCYTOSINE; FOSCARNET SODIUM; GANCICLOVIR; GRANISETRON; HALOPERIDOL; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE EMBONATE; INDINAVIR; ITRACONAZOLE; KETOCONAZOLE; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; LORAZEPAM; MECLOZINE; METOCLOPRAMIDE; METRONIDAZOLE; NELFINAVIR; NEVIRAPINE; OFLOXACIN; ONDANSETRON; PALONOSETRON; PAROMOMYCIN; PENTAMIDINE ISETHIONATE; PROCHLORPERAZINE; PROCHLORPERAZINE MALEATE; PROMETHAZINE; PROTON PUMP INHIBITOR; PYRIMETHAMINE; RIFABUTIN; RITONAVIR; SAQUINAVIR; SCOPOLAMINE; STAVUDINE; TENOFOVIR DISOPROXIL; THIOACETAZONE; TIBIONE; TRIMETHOBENZAMIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZIDOVUDINE;

AKATHISIA; DRUG HALF LIFE; DYSTONIA; GASTROINTESTINAL MOTILITY DISORDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NAUSEA AND VOMITING; ORTHOSTATIC HYPERTENSION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SEDATION; SIDE EFFECT; STOMACH PARESIS;

ANTI-INFECTIVE AGENTS; ANTIEMETICS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNICABLE DISEASES; GASTROPARESIS; HIV INFECTIONS; HUMANS; NAUSEA; VOMITING;

EID: 55849140875     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008244     Document Type: Review

References (30)

1. Karus D, Raveis V, Alexander C, et al. Patient reports of symptoms and their treatment at three palliative care projects servicing individuals with HIV/AIDS. J Pain Symptom Manage 2005;30:408-17
2. O'Brien M, Clark R, Besch L, et al. Adverse events are a leading cause for HIV treatment discontinuation. J Acquir Immune Defic Syndr 2003;34:407-14
3. Pasricha P. Treatment of disorders of bowel motility and water flux; antiemetics; agents used in biliary and pancreatic disease. In: Gilman AG, Brunton L, Lazo J, et al., eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 11th edn. New York: Pergamon, 2006:983-1019
4. Han P, Arnold B, Von Gunten C, et al. The challenge of chronic AIDS-related nausea and vomiting. J Palliat Med 2001;4:65-8
5. Sanford JP, Gilbert DN, Moellering RC, Sande MA. Sanford Guide: Guide to HIV/AIDS Therapy. 6th edn. Vienna, VA: Antimicrobial Therapy, 1997
6. Reynolds N, Neidig J, Vocca R. Patterns of nausea with combination antiretroviral induction (Abstract No. 12402). Int Conf AIDS 1998;12:94
7. Halloran J. HIV-related malignancies. In: Grimes DE, Grimes RM, eds. AIDS and HIV Infection. St Louis, MO: C.V. Mosby, 1994:140-52
8. Chabner B, Longo DL. Chemotherapy of neoplastic diseases. In: Gilman AG, Brunton L, Lazo J, et al., eds. Goodman & Gilman's the Pharmacological Basis of Therapeutics. 11th edn. New York: Pergamon, 2006:1315-403
9. Lichterfeld M, Qurishi N, Hoffman C, et al. Treatment of HIV-1-associated Kaposi's sarcoma with pegylated liposomal doxorubicin and HAART simultaneously induces effective tumor remission and CD4 T cell recovery. Infection 2005;33:140-7
10. Highleyman L. Managing nausea, vomiting, and diarrhea. Bull Expte Treatment for AIDS 2002;15:29-39
11. Fontes R, Vangeloti A, Pires ML, et al. Endocrine disorders in brazilian patients with acquired immune deficiency syndrome. Clin Infect Dis 2003;37:S137-41
12. Konturek JW, Fischer H, Van Der Voort IR, Domschke W. Disturbed gastric motor activity in patients with human immuno deficiency virus infection. Scand J Gastroenterol 1997;32:221-5
13. Neild PJ, Nijran KS, Yazaki E, et al. Delayed gastric emptying in human immunodeficiency virus infection. Dig Dis Sci 2000;45:1491-8
14. Miao YM, Gazzard BG. Management of protozoal diarrhea in HIV disease. HIV Med 2000;1:194-9
15. Blanshard C, Ellis DS, Tovey G, Gazzard BG. Electron microscopy of rectal biopsies in HIV-positive individuals. J Pathol 1993;169:79-87
16. Fessele KS. Managing the multiple causes of nausea and vomiting in the patient with cancer. Oncol Nurs Forum 1996;23:1409-15
17. Aapro M, Molassiotis A, Olver I. Anticipatory nausea and vomiting. Support Care Cancer 2005;13:117-21
18. Davey VA, Biederman GB. Conditioned antisickness: indirect evidence from rats and direct evidence from ferrets that conditioning alleviates drug-induced nausea and emesis. J Exptl Psychol Anim Behav Process 1998;24:483-91
19. Lett BT. Pavlovian drug-sickness pairings result in the conditioning of an antisickness response. Behav Neurosci 1983;97:779-84
20. Redd WH, Montgomery GH, DuHamel KN. Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst 2001;93:810-23
21. Razavi D, Delvaux N, Farvacques C, et al. Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. J Clin Oncol 1993;11:1384-90
22. Kemp C, Stepp L. Palliative care for patients with acquired immunodeficiency syndrome. Am J Hosp Palliat Care 1995;12:14-27
23. Gralla RJ, Osoba D, Kris MG, et al. Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. J Clin Oncol 1999;17:2971-94
24. Haney M, Rabkin J, Gunderson E, Foltin R. Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology 2005;181:170-8
25. Bouke C, Prentiss D, McFarland W, et al. Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. J Acquir Immune Defic Syndr 2005;38:43-6
26. Burish T, Carey M, Krozely M, Greco F. Conditioned side effects induced by cancer chemotherapy: prevention through behavioral treatment. J Consult Clin Psychol 1987;55:42-8
27. Connolly GM, Forbes A, Gleeson JA, Gazzard BG. Investigation of upper gastrointestinal symptoms in patients with AIDS. AIDS 1989;3:453-6
28. Stout BD, Leon MP, Niccolai LM. Nonadherence to antiretroviral therapy in HIV-positive patients in Costa Rica. AIDS Patient Care STDS 2004;18:297-304
29. Gompels M, McWilliams S, O'Hare M, Harris JRW, Pinching AJ, Main J. Ondansetron usage in HIV positive patients: a pilot study on the control of nausea and vomiting in patients on high dose co-trimoxazole for Pneumocystis carinii pneumonia. Int J STD AIDS 1993;4:293-6
30. Potter J, Higginson IJ. Frequency and severity of gastrointestinal symptoms in advanced cancer. In: Ripamonti C, Bruera E, eds. Gastrointestinal Symptoms in Advanced Cancer Patients. London: Oxford University Press, 2002:1-15